Sign in

CIK 0001628171 · Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472029180
Phone
650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-01 Anders Jack Chief Financial Officer Grant or award · Stock Option (Right to Buy) +45,400 45,400
2026-02-06 GOLDSMITH MARK A See Remarks Option exercise +24,010 $0.54 $13K 256,479
2026-02-06 GOLDSMITH MARK A See Remarks Option exercise · Stock Option (Right to Buy) −24,010 144,493
2026-01-21 Cislini Jeff General Counsel Sale 10b5-1 −908 $115.60 $105K 46,976
2026-01-07 Horn Margaret A Chief Operating Officer Option exercise 10b5-1 +51,406 $42.45 $2.2M 192,459
2026-01-07 Horn Margaret A Chief Operating Officer Option exercise 10b5-1 +23,594 $29.80 $703K 216,053
2026-01-07 Horn Margaret A Chief Operating Officer Sale 10b5-1 −53,096 $100.02 $5.3M 162,957
2026-01-07 Horn Margaret A Chief Operating Officer Sale 10b5-1 −20,204 $101.79 $2.1M 142,753
2026-01-07 Horn Margaret A Chief Operating Officer Sale 10b5-1 −1,700 $102.90 $175K 141,053
2026-01-07 Horn Margaret A Chief Operating Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −51,406 1,094
2026-01-07 Horn Margaret A Chief Operating Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −23,594 119,906
2026-01-07 Anders Jack Chief Financial Officer Option exercise 10b5-1 +10,000 $42.45 $425K 118,065
2026-01-07 Anders Jack Chief Financial Officer Sale 10b5-1 −10,000 $98.00 $980K 108,065
2026-01-07 Anders Jack Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 15,900
2025-12-16 Cislini Jeff General Counsel Sale 10b5-1 −2,688 $76.82 $206K 47,884
2025-12-16 GOLDSMITH MARK A See Remarks Sale 10b5-1 −15,394 $76.82 $1.2M 232,469
2025-12-16 Kelsey Stephen Michael See Remarks Sale 10b5-1 −5,447 $76.82 $418K 278,600
2025-12-16 Horn Margaret A Chief Operating Officer Sale 10b5-1 −4,847 $76.82 $372K 141,053
2025-12-16 Anders Jack Chief Financial Officer Sale 10b5-1 −3,104 $77.09 $239K 108,065
2025-11-25 Anders Jack Chief Financial Officer Option exercise 10b5-1 +5,418 $17.00 $92K 116,412

Page 13 of 18 · 352 trades